8.19 USD
▲+0.05+0.74%
盘后 8.13 0.00%
2026-08-03
市值
$1.48B
市盈率
127.76
EPS
0.06
股息率
—
52 周区间
5.25 – 10.08
成交量
1.84M
Beta
0.85
目标价
11.29
52W 低 5.2552W 高 10.08
价格走势
公司简介
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patient...